Qualitest Pharmaceuticals
130 Vintage Drive NE
Huntsville
Alabama
35811
United States
Tel: 256-859-4011
18 articles about Qualitest Pharmaceuticals
-
Endo International's Qualitest to Lay Off 300 in Shuttering of Its North Carolina Facility
11/4/2016
-
Qualitest Pharmaceuticals Issues Voluntary, Nationwide Recall of Hydrocodone Bitartrate and Acetaminophen Tablets
12/7/2012
-
Qualitest Pharmaceuticals Issues Voluntary, Nationwide Recall for One Lot of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized Tablets
9/11/2012
-
Qualitest Pharmaceuticals Launches Generic Singulair®
8/6/2012
-
Qualitest Pharmaceuticals Receives FDA Approval for Levetiracetam Extended-Release Tablets, 500mg and 750mg
7/25/2012
-
Qualitest Pharmaceuticals Receives FDA Approval for Myzilra™ Tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, 0.125 mg/0.03 mg (28 - Day TriPhasic Regimen)
11/29/2011
-
Qualitest Pharmaceuticals Receives FDA Approval for Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL
11/14/2011
-
Qualitest Pharmaceuticals Pharma Recalls Oral Contraceptives
9/16/2011
-
Qualitest Pharmaceuticals Issues Voluntary, Nationwide Retail Level Recall of Four Lots of Butalbital, Acetaminophen, and Caffeine Tablets, USP 50mg/325mg/40mg and Four Lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5MG/500MG
6/27/2011
-
Qualitest Pharmaceuticals Receives FDA Approval for Dexamethasone Elixir, USP, 0.5mg/ 5 mL and Orsythia(TM) Tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.1 mg/0.02 mg)
5/19/2011
-
Qualitest Pharmaceuticals Receives FDA Approval for Toresmide Tablets (Generic Demadex(r)) 5 mg, 10 mg, 20 mg, 100 mg, for the Treatment of Edema Associated with Congestive Heart Failure, Renal Disease, or Hepatic Disease
3/24/2011
-
Qualitest Pharmaceuticals Receives FDA Approval for Emoquette(TM) (.15 mg Desogestrel and .03 mg Ethinyl Estradiol), an Oral Contraceptive for Prevention of Pregnancy
3/4/2011
-
Qualitest Pharmaceuticals Issues Voluntary, Nationwide Recall of Hydrocodone Bitartrate and Acetaminophen Tablets
2/7/2011
-
Endo Pharmaceuticals Successfully Completes Acquisition of Qualitest Pharmaceuticals for $1.2 Billion
12/1/2010
-
Apax Partners & Co. to Sell Qualitest Pharmaceuticals to Endo Pharmaceuticals for $1.2 Billion
9/28/2010
-
Qualitest Pharmaceuticals Names Pharmaceutical Industry Veteran Robert Mills as the Company's New President
5/19/2010
-
Qualitest Pharmaceuticals Appoints Ronald Johnson to Board of Directors
5/13/2010
-
Qualitest Pharmaceuticals Issues a Voluntary Nationwide Recall of All Accusure(R) Insulin Syringes
10/28/2009